Ann: Chairman's Address and Presentation to AGM, page-60

Next generation HIV-1 drug is currently in preliminary safety testing.
Does that mean it is being fed to animals?

It should also be noted that BIT225 was not designed for Sars Cov.
There is a cohort of specialised compounds being tested, (on the 23rd of November 2021), in SARS-CoV-2 animal models in the USA.
We don't have those results yet.
These molecules were also, (on 23/11/2021), in preclinical safety studies.
Results before the end of 2021.

So anytime in the next 4 weeks.

Another thing of note is the repeated use of 'HIV Eradication' being thrown about. Why are they suddenly so incautious?